| ZFIN ID: ZDB-PUB-060921-27 |
A chemical and genetic approach to the mode of action of fumagillin
Zhang, Y., Yeh, J.R., Mara, A., Ju, R., Hines, J.F., Cirone, P., Griesbach, H.L., Schneider, I., Slusarski, D.C., Holley, S.A., and Crews, C.M.
| Date: | 2006 |
|---|---|
| Source: | Chemistry & Biology 13(9): 1001-1009 (Journal) |
| Registered Authors: | Slusarski, Diane C. |
| Keywords: | none |
| MeSH Terms: |
|
| PubMed: | 16984890 Full text @ Chem. Biol. |
Citation
Zhang, Y., Yeh, J.R., Mara, A., Ju, R., Hines, J.F., Cirone, P., Griesbach, H.L., Schneider, I., Slusarski, D.C., Holley, S.A., and Crews, C.M. (2006) A chemical and genetic approach to the mode of action of fumagillin. Chemistry & Biology. 13(9):1001-1009.
ABSTRACT
Previous mode of action studies identified methionine aminopeptidase 2 (MetAP-2) as the target of the antiangiogenic natural product fumagillin and its drug candidate analog, TNP-470. We report here that TNP-470-mediated MetAP-2 inhibition blocks noncanonical Wnt signaling, which plays a critical role in development, cell differentiation, and tumorigenesis. Consistent with this finding, antisense MetAP-2 morpholino oligonucleotide injection in zebrafish embryos phenocopies gastrulation defects seen in noncanonical Wnt5 loss-of-function zebrafish mutants. MetAP-2 inhibition or depletion blocks signaling downstream of the Wnt receptor Frizzled, but upstream of Calmodulin-dependent Kinase II, RhoA, and c-Jun N-terminal Kinase. Moreover, we demonstrate that TNP-470 does not block the canonical Wnt/beta-catenin pathway. Thus, TNP-470 selectively regulates noncanonical over canonical Wnt signaling and provides a unique means to explore and dissect the biological systems mediated by these pathways.
ADDITIONAL INFORMATION